The best of times, the worst of times: the wealth and poverty of heart failure pharmacotherapies: is there a role for vesnarinone?
Young
James B
JB
Department of Medicine, CCF Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA.
D002986:Clinical Trials as Topic; D004358:Drug Therapy / Q000191:economics*; D005544:Forecasting; D006333:Heart Failure / Q000188:drug therapy* / Q000191:economics / Q000401:mortality; D006801:Humans; D011719:Pyrazines; D011804:Quinolines / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D015363:Quinolones / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D012959:Socioeconomic Factors; D013997:Time Factors
D011719:Pyrazines; D011804:Quinolines; D015363:Quinolones; C041667:vesnarinone